BeiGene continued its global expansion march with the opening of its $800 million U.S. flagship biologics manufacturing and R&D facility in Hopewell, New Jersey.
The 400,000-square-foot production site, which was constructed over a three-year period, is expected to “create hundreds of skilled high-tech jobs at the site by the end of 2025,” the company said in a July 23 press release.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,